Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer

N/ATerminatedNCT01975597

University of Michigan Rogel Cancer Center8 enrolled

Overview

This is a feasibility study to demonstrate the team's ability to collect bone marrow aspirates and biopsies for research purposes from women with metastatic breast cancer.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Metastatic Breast Cancer

Interventions

Bone marrow aspirates and biopsyPROCEDURE

Eligibility

Sex: ALLMin age: 21 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with metastatic breast cancer (any site) age 21 or older * Patients willing and able to provide informed consent \& perform study procedures * Patients may enroll with recently (with 2 months) progressive tumor burden * Performance status of 0,1 or 2 Exclusion Criteria: * Patients unable or unwilling to provide informed consent and or perform study procedures * Patients with active, uncontrolled coagulopathy * Patients on treatment dose anticoagulation or an International Normalised Ratio of 2 or greater if on warfarin * Patients who are known to be pregnant are not eligible to participate in this study during the time of the pregnancy

Locations (1)

University of Michigan

Ann Arbor, Michigan, United States

Outcomes

Primary Outcomes

Number of patient that agree to undergo 2 biopsy's strictly for research purposes.

Time frame: At 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.